Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The primary objectives of the study are to evaluate the effects of two doses of nalbuphine
HCl ER tablets on the change from baseline in the worst itch Numerical Rating Scale (NRS) in
patients with prurigo nodularis and to evaluate the safety and tolerability in the study
population.